Skip to content

Logopedic self-intervention program in voice therapy

Logopedic self-intervention program in voice therapy - LIPS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038577
Enrollment
96
Registered
2026-01-23
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R49.0

Interventions

Group 1: Group A: Care as usual, 10 therapy sessions with a speech and language therapist in a 1:1 setting Group 2: Group B1: 5 therapy sessions 1:1 with a speech and language therapist, every second

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Language requirements for informed participation, answering questions, and undergoing therapy • Medically diagnosed functional dysphonia • Initial prescription for voice therapy (ST2) • VHI-30 was administered

Exclusion criteria

Exclusion criteria: • No functional voice disorder (e.g., organic cause) • Desire for therapy to transition the voice in trans patients • Already undergoing voice therapy treatment • Therapy for professional singers' voices • Non-consent

Design outcomes

Primary

MeasureTime frame
The primary endpoint for assessing the non-inferiority of the various SIP programs compared to standard therapy is the improvement in functional, physical, and emotional aspects of the voice disorder as measured by the Voice Handicap Index (VHI-30) before inclusion in the study and up to 12 weeks after the t0 measurement (t1). The VHI-30 is a questionnaire that assesses functional, physical, and emotional aspects of a voice disorder, each of which is subjectively rated by the patient on a five-point scale and added up to a total score.

Secondary

MeasureTime frame
Beyond the primary proof of efficacy, the following secondary questions regarding the efficacy of the different self-learning programmes should be answered: - Do voice parameters in groups B1, B2 and C improve by at least the same amount as in group A (the standard therapy group) from t0 to t1? - Are the medium-term effects on voice parameters (t2, eight months after diagnosis at t0) in groups B1, B2 and C at least as good as in group A? - Are there differences in effectiveness between the different therapy settings? - Are certain patient groups particularly suited to one form of therapy? - Which factors (including gender, age and living conditions) are conducive to or detrimental to the success of the therapy? PROCESS EVALUATION: The following questions will be answered based on a combination of the results of the process and effectiveness evaluations: - Does the preference expressed with regard to the design of the self-learning programme influence the voting results and frequency of participation? - How does satisfaction with the respective self-learning programme influence effectiveness outcomes? ACCOMPANYING RESEARCH In preparation for the start of recruitment, focus groups with consensus procedures based on the Delphi method are to be initiated before the start of the study with a group of prescribers (ENT doctors and phoniatrists) to establish uniform criteria for an ST2 prescription. In addition to the planned process evaluation with the recruited patients in the RCT, interviews with treating speech therapists will be conducted for each study arm to answer the following question: - How well can group and individual therapy be implemented in combination with EL from the therapists' perspective?

Countries

Germany

Contacts

Public ContactSimone Miller

Medizinische Hochschule Hannover

miller.simone@mh-hannover.de+495115325778

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026